CVS vs. DXCM: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at CVS and DXCM, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
Symbol | CVS | DXCM |
---|---|---|
Company Name | CVS Health Corporation | DexCom, Inc. |
Country | United States | United States |
GICS Sector | Health Care | Health Care |
GICS Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
Market Capitalization | 98.28 billion USD | 26.29 billion USD |
Exchange | NYSE | NasdaqGS |
Listing Date | February 21, 1973 | April 14, 2005 |
Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of CVS and DXCM by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
Symbol | CVS | DXCM |
---|---|---|
5-Day Price Return | 2.54% | 0.89% |
13-Week Price Return | 14.92% | -19.15% |
26-Week Price Return | 14.38% | -1.82% |
52-Week Price Return | 24.50% | -0.07% |
Month-to-Date Return | 2.79% | -0.36% |
Year-to-Date Return | 72.62% | -13.78% |
10-Day Avg. Volume | 6.88M | 6.50M |
3-Month Avg. Volume | 7.51M | 4.32M |
3-Month Volatility | 26.09% | 41.38% |
Beta | 0.48 | 1.53 |
Profitability
Return on Equity (TTM)
CVS
5.95%
Health Care Providers & Services Industry
- Max
- 24.86%
- Q3
- 15.79%
- Median
- 8.56%
- Q1
- 5.75%
- Min
- -1.64%
CVS’s Return on Equity of 5.95% is on par with the norm for the Health Care Providers & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.
DXCM
25.62%
Health Care Equipment & Supplies Industry
- Max
- 29.93%
- Q3
- 16.99%
- Median
- 9.28%
- Q1
- 5.10%
- Min
- -12.52%
In the upper quartile for the Health Care Equipment & Supplies industry, DXCM’s Return on Equity of 25.62% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Net Profit Margin (TTM)
CVS
1.17%
Health Care Providers & Services Industry
- Max
- 11.56%
- Q3
- 5.45%
- Median
- 2.83%
- Q1
- 1.13%
- Min
- -1.71%
CVS’s Net Profit Margin of 1.17% is aligned with the median group of its peers in the Health Care Providers & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
DXCM
13.29%
Health Care Equipment & Supplies Industry
- Max
- 24.41%
- Q3
- 13.71%
- Median
- 10.08%
- Q1
- 5.96%
- Min
- -5.58%
DXCM’s Net Profit Margin of 13.29% is aligned with the median group of its peers in the Health Care Equipment & Supplies industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
CVS
2.44%
Health Care Providers & Services Industry
- Max
- 19.08%
- Q3
- 9.66%
- Median
- 4.77%
- Q1
- 2.46%
- Min
- -0.83%
CVS’s Operating Profit Margin of 2.44% is in the lower quartile for the Health Care Providers & Services industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.
DXCM
15.98%
Health Care Equipment & Supplies Industry
- Max
- 31.09%
- Q3
- 18.11%
- Median
- 15.07%
- Q1
- 8.48%
- Min
- -0.28%
DXCM’s Operating Profit Margin of 15.98% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
Symbol | CVS | DXCM |
---|---|---|
Return on Equity (TTM) | 5.95% | 25.62% |
Return on Assets (TTM) | 1.78% | 8.49% |
Net Profit Margin (TTM) | 1.17% | 13.29% |
Operating Profit Margin (TTM) | 2.44% | 15.98% |
Gross Profit Margin (TTM) | 13.82% | 60.01% |
Financial Strength
Current Ratio (MRQ)
CVS
0.80
Health Care Providers & Services Industry
- Max
- 2.00
- Q3
- 1.51
- Median
- 1.29
- Q1
- 0.92
- Min
- 0.14
CVS’s Current Ratio of 0.80 falls into the lower quartile for the Health Care Providers & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
DXCM
1.52
Health Care Equipment & Supplies Industry
- Max
- 5.19
- Q3
- 3.00
- Median
- 2.13
- Q1
- 1.44
- Min
- 0.86
DXCM’s Current Ratio of 1.52 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
CVS
0.86
Health Care Providers & Services Industry
- Max
- 2.29
- Q3
- 1.24
- Median
- 0.74
- Q1
- 0.50
- Min
- 0.00
CVS’s Debt-to-Equity Ratio of 0.86 is typical for the Health Care Providers & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
DXCM
0.97
Health Care Equipment & Supplies Industry
- Max
- 1.61
- Q3
- 0.76
- Median
- 0.45
- Q1
- 0.14
- Min
- 0.00
DXCM’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 0.97. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.
Interest Coverage Ratio (TTM)
CVS
3.08
Health Care Providers & Services Industry
- Max
- 14.47
- Q3
- 7.50
- Median
- 4.52
- Q1
- 2.12
- Min
- -4.44
CVS’s Interest Coverage Ratio of 3.08 is positioned comfortably within the norm for the Health Care Providers & Services industry, indicating a standard and healthy capacity to cover its interest payments.
DXCM
978.00
Health Care Equipment & Supplies Industry
- Max
- 56.35
- Q3
- 25.56
- Median
- 9.60
- Q1
- 3.78
- Min
- -26.49
With an Interest Coverage Ratio of 978.00, DXCM demonstrates a superior capacity to service its debt, placing it well above the typical range for the Health Care Equipment & Supplies industry. This stems from either robust earnings or a conservative debt load.
Financial Strength at a Glance
Symbol | CVS | DXCM |
---|---|---|
Current Ratio (MRQ) | 0.80 | 1.52 |
Quick Ratio (MRQ) | 0.62 | 1.32 |
Debt-to-Equity Ratio (MRQ) | 0.86 | 0.97 |
Interest Coverage Ratio (TTM) | 3.08 | 978.00 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
CVS
3.40%
Health Care Providers & Services Industry
- Max
- 5.93%
- Q3
- 2.59%
- Median
- 1.35%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 3.40%, CVS offers a more attractive income stream than most of its peers in the Health Care Providers & Services industry, signaling a strong commitment to shareholder returns.
DXCM
0.00%
Health Care Equipment & Supplies Industry
- Max
- 4.15%
- Q3
- 1.76%
- Median
- 0.79%
- Q1
- 0.00%
- Min
- 0.00%
DXCM currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio (TTM)
CVS
74.62%
Health Care Providers & Services Industry
- Max
- 185.33%
- Q3
- 74.82%
- Median
- 36.00%
- Q1
- 0.00%
- Min
- 0.00%
CVS’s Dividend Payout Ratio of 74.62% is within the typical range for the Health Care Providers & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
DXCM
0.00%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 66.60%
- Median
- 27.49%
- Q1
- 0.00%
- Min
- 0.00%
DXCM has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
Symbol | CVS | DXCM |
---|---|---|
Dividend Yield (TTM) | 3.40% | 0.00% |
Dividend Payout Ratio (TTM) | 74.62% | 0.00% |
Valuation
Price-to-Earnings Ratio (TTM)
CVS
21.93
Health Care Providers & Services Industry
- Max
- 40.02
- Q3
- 29.75
- Median
- 21.09
- Q1
- 14.18
- Min
- 7.05
CVS’s P/E Ratio of 21.93 is within the middle range for the Health Care Providers & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
DXCM
45.59
Health Care Equipment & Supplies Industry
- Max
- 67.29
- Q3
- 47.01
- Median
- 30.94
- Q1
- 23.91
- Min
- 10.79
DXCM’s P/E Ratio of 45.59 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
CVS
0.26
Health Care Providers & Services Industry
- Max
- 3.15
- Q3
- 1.87
- Median
- 0.74
- Q1
- 0.27
- Min
- 0.09
In the lower quartile for the Health Care Providers & Services industry, CVS’s P/S Ratio of 0.26 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.
DXCM
6.06
Health Care Equipment & Supplies Industry
- Max
- 9.49
- Q3
- 5.41
- Median
- 2.86
- Q1
- 2.07
- Min
- 0.74
DXCM’s P/S Ratio of 6.06 is in the upper echelon for the Health Care Equipment & Supplies industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.
Price-to-Book Ratio (MRQ)
CVS
1.13
Health Care Providers & Services Industry
- Max
- 7.33
- Q3
- 4.45
- Median
- 2.52
- Q1
- 1.15
- Min
- 0.66
CVS’s P/B Ratio of 1.13 is in the lower quartile for the Health Care Providers & Services industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
DXCM
13.30
Health Care Equipment & Supplies Industry
- Max
- 10.85
- Q3
- 6.56
- Median
- 3.53
- Q1
- 2.36
- Min
- 0.71
At 13.30, DXCM’s P/B Ratio is at an extreme premium to the Health Care Equipment & Supplies industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.
Valuation at a Glance
Symbol | CVS | DXCM |
---|---|---|
Price-to-Earnings Ratio (TTM) | 21.93 | 45.59 |
Price-to-Sales Ratio (TTM) | 0.26 | 6.06 |
Price-to-Book Ratio (MRQ) | 1.13 | 13.30 |
Price-to-Free Cash Flow Ratio (TTM) | 16.04 | 45.65 |